Published in J Pineal Res on December 13, 2007
Antiinflammatory activity of melatonin in central nervous system. Curr Neuropharmacol (2010) 1.09
Spinal cord injury: a review of current therapy, future treatments, and basic science frontiers. Neurochem Res (2013) 1.08
Inhibition of cysteine proteases in acute and chronic spinal cord injury. Neurotherapeutics (2011) 1.02
Calpeptin attenuated inflammation, cell death, and axonal damage in animal model of multiple sclerosis. J Neurosci Res (2010) 0.99
Oxidative stress, DNA damage, and the telomeric complex as therapeutic targets in acute neurodegeneration. Neurochem Int (2013) 0.92
Cytoprotective effects of melatonin on C6 astroglial cells exposed to glutamate excitotoxicity and oxidative stress. J Pineal Res (2008) 0.90
Neurotrauma and mesenchymal stem cells treatment: From experimental studies to clinical trials. World J Stem Cells (2014) 0.90
Dantrolene can reduce secondary damage after spinal cord injury. Eur Spine J (2009) 0.90
Administration of low dose estrogen attenuates gliosis and protects neurons in acute spinal cord injury in rats. J Neurochem (2016) 0.89
Physiological low dose of estrogen-protected neurons in experimental spinal cord injury. Ann N Y Acad Sci (2010) 0.88
Low dose estrogen prevents neuronal degeneration and microglial reactivity in an acute model of spinal cord injury: effect of dosing, route of administration, and therapy delay. Neurochem Res (2011) 0.86
Cellular and biochemical actions of melatonin which protect against free radicals: role in neurodegenerative disorders. Curr Neuropharmacol (2008) 0.83
Location and level of Etk expression in neurons are associated with varied severity of traumatic brain injury. PLoS One (2012) 0.81
Does dexmedetomidine reduce secondary damage after spinal cord injury? An experimental study. Eur Spine J (2009) 0.80
Effect of melatonin on the functional recovery from experimental traumatic compression of the spinal cord. Braz J Med Biol Res (2013) 0.79
Neuronal cell differentiation of mesenchymal stem cells originating from canine amniotic fluid. Hum Cell (2013) 0.79
Recent advances in the pharmacologic treatment of spinal cord injury. Metab Brain Dis (2014) 0.79
Melatonin Reverses Fas, E2F-1 and Endoplasmic Reticulum Stress Mediated Apoptosis and Dysregulation of Autophagy Induced by the Herbicide Atrazine in Murine Splenocytes. PLoS One (2014) 0.78
Differential effects of early postinjury treatment with neuroprotective drugs in a mouse model using diffuse reflectance spectroscopy. Neurophotonics (2015) 0.76
New Prophylactic and Therapeutic Strategies for Spinal Cord Injury. J Lifestyle Med (2013) 0.75
The effect of melatonin on spinal cord after ischemia in rats. Spinal Cord (2015) 0.75
Melatonin lowers edema after spinal cord injury. Neural Regen Res (2014) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A (1979) 365.71
The glial scar and central nervous system repair. Brain Res Bull (1999) 4.80
Methylprednisolone for acute spinal cord injury: an inappropriate standard of care. J Neurosurg (2000) 3.59
Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data. Results of the second National Acute Spinal Cord Injury Study. J Neurosurg (1992) 3.52
One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species? J Pineal Res (2007) 2.84
Non-erythroid alpha-spectrin breakdown by calpain and interleukin 1 beta-converting-enzyme-like protease(s) in apoptotic cells: contributory roles of both protease families in neuronal apoptosis. Biochem J (1996) 2.05
Bax cleavage is mediated by calpain during drug-induced apoptosis. Oncogene (1998) 1.79
Synergistic activation of caspase-3 by m-calpain after neonatal hypoxia-ischemia: a mechanism of "pathological apoptosis"? J Biol Chem (2000) 1.77
Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger. Curr Top Med Chem (2002) 1.75
Inhibition of calpains prevents neuronal and behavioral deficits in an MPTP mouse model of Parkinson's disease. J Neurosci (2003) 1.74
Critical role of calpain-mediated cleavage of calcineurin in excitotoxic neurodegeneration. J Biol Chem (2003) 1.55
Biochemical reactivity of melatonin with reactive oxygen and nitrogen species: a review of the evidence. Cell Biochem Biophys (2001) 1.52
Calpain and its involvement in the pathophysiology of CNS injuries and diseases: therapeutic potential of calpain inhibitors for prevention of neurodegeneration. Curr Drug Targets CNS Neurol Disord (2003) 1.47
Estrogen attenuated markers of inflammation and decreased lesion volume in acute spinal cord injury in rats. J Neurosci Res (2005) 1.46
Oxidative damage in the central nervous system: protection by melatonin. Prog Neurobiol (1998) 1.34
The chemistry of melatonin's interaction with reactive species. J Pineal Res (2003) 1.34
Calpain activation in apoptosis of ventral spinal cord 4.1 (VSC4.1) motoneurons exposed to glutamate: calpain inhibition provides functional neuroprotection. J Neurosci Res (2005) 1.27
Estrogen attenuates oxidative stress-induced apoptosis in C6 glial cells. Brain Res (2003) 1.23
Calpain in the pathophysiology of spinal cord injury: neuroprotection with calpain inhibitors. Brain Res Brain Res Rev (2003) 1.22
Melatonin-immune system relationships. Curr Top Med Chem (2002) 1.21
Melatonin and mitochondrial function. Life Sci (2004) 1.20
Estrogen treatment of spinal cord injury attenuates calpain activation and apoptosis. J Neurosci Res (2006) 1.17
Calpain inhibitor AK295 attenuates motor and cognitive deficits following experimental brain injury in the rat. Proc Natl Acad Sci U S A (1996) 1.15
The calpain small subunit gene is essential: its inactivation results in embryonic lethality. IUBMB Life (2000) 1.14
Attenuation in the evolution of experimental spinal cord trauma by treatment with melatonin. J Pineal Res (2005) 1.11
The potential of melatonin in reducing morbidity-mortality after craniocerebral trauma. J Pineal Res (2007) 1.08
Implication of calpain in neuronal apoptosis. A possible regulation of Alzheimer's disease. FEBS J (2006) 1.08
Melatonin-induced neuroprotection after closed head injury is associated with increased brain antioxidants and attenuated late-phase activation of NF-kappaB and AP-1. FASEB J (2003) 1.07
When melatonin gets on your nerves: its beneficial actions in experimental models of stroke. Exp Biol Med (Maywood) (2005) 1.06
Visualization of the antioxidative effects of melatonin at the mitochondrial level during oxidative stress-induced apoptosis of rat brain astrocytes. J Pineal Res (2004) 1.05
Estrogen prevents glutamate-induced apoptosis in C6 glioma cells by a receptor-mediated mechanism. Neuroscience (2005) 1.04
Protective effect of melatonin on experimental spinal cord ischemia. Spinal Cord (2003) 1.02
Astrocytosis, microglia activation, oligodendrocyte degeneration, and pyknosis following acute spinal cord injury. Exp Neurol (2004) 1.00
Combined TUNEL and double immunofluorescent labeling for detection of apoptotic mononuclear phagocytes in autoimmune demyelinating disease. Brain Res Brain Res Protoc (2000) 0.97
Potent protective effects of melatonin on experimental spinal cord injury. Spine (Phila Pa 1976) (2000) 0.96
Melatonin reduces oxidant damage and promotes mitochondrial respiration: implications for aging. Ann N Y Acad Sci (2002) 0.96
Comparison of the effects of melatonin and methylprednisolone in experimental spinal cord injury. J Neurosurg (2000) 0.94
Therapeutic model for experimental spinal cord injury in the rat: I. Mortality and motor deficit. Cent Nerv Syst Trauma (1987) 0.94
Melatonin attenuates arsenite-induced apoptosis in rat brain: involvement of mitochondrial and endoplasmic reticulum pathways and aggregation of alpha-synuclein. J Pineal Res (2007) 0.93
Calpain activation and cytoskeletal protein breakdown in the corpus callosum of head-injured patients. J Neurotrauma (1999) 0.93
Neurofilament 68 and neurofilament 200 protein levels decrease after traumatic brain injury. J Neurotrauma (1994) 0.92
The parkinsonian neurotoxin rotenone activates calpain and caspase-3 leading to motoneuron degeneration in spinal cord of Lewis rats. Neuroscience (2007) 0.91
Acute spinal cord injury, part II: contemporary pharmacotherapy. Clin Neuropharmacol (2001) 0.90
Early induction of secondary injury factors causing activation of calpain and mitochondria-mediated neuronal apoptosis following spinal cord injury in rats. J Neurosci Res (2003) 0.90
Calpain and calpastatin expression in primary oligodendrocyte culture: preferential localization of membrane calpain in cell processes. J Neurosci Res (2002) 0.89
Melatonin antagonizes apoptosis via receptor interaction in U937 monocytic cells. J Pineal Res (2007) 0.89
Cell death in spinal cord injury (SCI) requires de novo protein synthesis. Calpain inhibitor E-64-d provides neuroprotection in SCI lesion and penumbra. Ann N Y Acad Sci (2001) 0.88
Calpain activity and expression increased in activated glial and inflammatory cells in penumbra of spinal cord injury lesion. J Neurosci Res (2000) 0.88
Effects of combination of melatonin and dexamethasone on secondary injury in an experimental mice model of spinal cord trauma. J Pineal Res (2007) 0.88
Diverse stimuli induce calpain overexpression and apoptosis in C6 glioma cells. Brain Res (1999) 0.86
Beta-amyloid modulates tyrosine kinase B receptor expression in SHSY5Y neuroblastoma cells: influence of the antioxidant melatonin. Neuroscience (2003) 0.86
Effect of combined treatment with melatonin and methylprednisolone on neurological recovery after experimental spinal cord injury. Eur Spine J (2004) 0.85
Pharmacological actions of melatonin in acute and chronic inflammation. Curr Top Med Chem (2002) 0.85
Immunofluorescent labeling of increased calpain expression and neuronal death in the spinal cord of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice. Brain Res (2004) 0.84
Calcium-activated neutral proteinase in rat brain myelin and subcellular fractions. J Neurosci Res (1988) 0.82
Antioxidation of melatonin against spinal cord injury in rats. Chin Med J (Engl) (2004) 0.81
Interaction of melatonin with model membranes and possible implications in its photoprotective activity. Eur J Pharm Biopharm (2002) 0.79
Role of calpain in spinal cord injury: increased mcalpain immunoreactivity in spinal cord after compression injury in the rat. Neurochem Int (1996) 0.78
Acute traumatic spinal cord injury, 1993-2000A population-based assessment of methylprednisolone administration and hospitalization. J Trauma (2004) 0.77
Melatonin, metals, and gene expression: implications in aging and neurodegenerative disorders. Ann N Y Acad Sci (2004) 0.76
Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08
Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res (2004) 2.87
One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species? J Pineal Res (2007) 2.84
Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases. Brain Res Bull (2011) 2.22
Melatonin as a natural ally against oxidative stress: a physicochemical examination. J Pineal Res (2011) 2.12
Melatonin: from basic research to cancer treatment clinics. J Clin Oncol (2002) 1.99
Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger. Curr Top Med Chem (2002) 1.75
On the free radical scavenging activities of melatonin's metabolites, AFMK and AMK. J Pineal Res (2012) 1.60
A review of the multiple actions of melatonin on the immune system. Endocrine (2005) 1.55
Melatonin reduces the severity of anesthesia-induced apoptotic neurodegeneration in the developing rat brain. Neurobiol Dis (2005) 1.52
Calpain and its involvement in the pathophysiology of CNS injuries and diseases: therapeutic potential of calpain inhibitors for prevention of neurodegeneration. Curr Drug Targets CNS Neurol Disord (2003) 1.47
Effects of a novel orally administered calpain inhibitor SNJ-1945 on immunomodulation and neurodegeneration in a murine model of multiple sclerosis. J Neurochem (2014) 1.47
Melatonin membrane receptors in peripheral tissues: distribution and functions. Mol Cell Endocrinol (2012) 1.47
Dexamethasone protected human glioblastoma U87MG cells from temozolomide induced apoptosis by maintaining Bax:Bcl-2 ratio and preventing proteolytic activities. Mol Cancer (2004) 1.46
Flavonoids activated caspases for apoptosis in human glioblastoma T98G and U87MG cells but not in human normal astrocytes. Cancer (2010) 1.41
Oxidative stress impairs oocyte quality and melatonin protects oocytes from free radical damage and improves fertilization rate. J Pineal Res (2008) 1.40
Drug resistance in glioblastoma: a mini review. Neurochem Res (2012) 1.36
Extrapineal melatonin: sources, regulation, and potential functions. Cell Mol Life Sci (2014) 1.31
Mechanism of apoptosis with the involvement of calpain and caspase cascades in human malignant neuroblastoma SH-SY5Y cells exposed to flavonoids. Int J Cancer (2006) 1.30
Kynuramines, metabolites of melatonin and other indoles: the resurrection of an almost forgotten class of biogenic amines. J Pineal Res (2009) 1.29
Melatonin and the ovary: physiological and pathophysiological implications. Fertil Steril (2008) 1.29
Calpain activation in apoptosis of ventral spinal cord 4.1 (VSC4.1) motoneurons exposed to glutamate: calpain inhibition provides functional neuroprotection. J Neurosci Res (2005) 1.27
Melatonin mitigates mitochondrial malfunction. J Pineal Res (2005) 1.27
Causes of oxidative stress in the pre- and perinatal period. Biol Neonate (2002) 1.26
Melatonin as a radioprotective agent: a review. Int J Radiat Oncol Biol Phys (2004) 1.25
The effects of calpain inhibition on IkB alpha degradation after activation of PBMCs: identification of the calpain cleavage sites. Neurochem Res (2004) 1.23
Melatonin: a hormone, a tissue factor, an autocoid, a paracoid, and an antioxidant vitamin. J Pineal Res (2003) 1.23
Differentiation decreased telomerase activity in rat glioblastoma C6 cells and increased sensitivity to IFN-gamma and taxol for apoptosis. Neurochem Res (2007) 1.23
Calpain in the pathophysiology of spinal cord injury: neuroprotection with calpain inhibitors. Brain Res Brain Res Rev (2003) 1.22
A review of the molecular aspects of melatonin's anti-inflammatory actions: recent insights and new perspectives. J Pineal Res (2012) 1.21
Melatonin-immune system relationships. Curr Top Med Chem (2002) 1.21
Oxidative stress of the newborn in the pre- and postnatal period and the clinical utility of melatonin. J Pineal Res (2008) 1.21
Melatonin and mitochondrial function. Life Sci (2004) 1.20
Sodium phenylacetate inhibits adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice at multiple steps. J Immunol (2003) 1.20
Garlic compounds generate reactive oxygen species leading to activation of stress kinases and cysteine proteases for apoptosis in human glioblastoma T98G and U87MG cells. Cancer (2007) 1.20
Protective effects of melatonin in reducing oxidative stress and in preserving the fluidity of biological membranes: a review. J Pineal Res (2014) 1.20
Melatonin, the circadian multioscillator system and health: the need for detailed analyses of peripheral melatonin signaling. J Pineal Res (2011) 1.20
Analgesic effects of melatonin: a review of current evidence from experimental and clinical studies. J Pineal Res (2011) 1.19
Functional roles of melatonin in plants, and perspectives in nutritional and agricultural science. J Exp Bot (2011) 1.19
Extrapineal melatonin: analysis of its subcellular distribution and daily fluctuations. J Pineal Res (2011) 1.18
Evidence of melatonin synthesis by human lymphocytes and its physiological significance: possible role as intracrine, autocrine, and/or paracrine substance. FASEB J (2004) 1.17
Melatonin and pregnancy in the human. Reprod Toxicol (2008) 1.17
Defining chronodisruption. J Pineal Res (2009) 1.17
Mitochondria and chloroplasts as the original sites of melatonin synthesis: a hypothesis related to melatonin's primary function and evolution in eukaryotes. J Pineal Res (2012) 1.15
Anti-inflammatory actions of melatonin and its metabolites, N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) and N1-acetyl-5-methoxykynuramine (AMK), in macrophages. J Neuroimmunol (2005) 1.14
Curcumin activated both receptor-mediated and mitochondria-mediated proteolytic pathways for apoptosis in human glioblastoma T98G cells. Neurosci Lett (2006) 1.10
Shift work and cancer: the evidence and the challenge. Dtsch Arztebl Int (2010) 1.10
Cardiovascular diseases: protective effects of melatonin. J Pineal Res (2008) 1.10
Dexamethasone decreases temozolomide-induced apoptosis in human gliobastoma T98G cells. Glia (2005) 1.10
Phytomelatonin: a review. J Exp Bot (2008) 1.09
Melatonin reduces prostate cancer cell growth leading to neuroendocrine differentiation via a receptor and PKA independent mechanism. Prostate (2005) 1.08
Chronodisruption and cancer. Naturwissenschaften (2008) 1.08
Melatonin alleviates lung damage induced by the chemical warfare agent nitrogen mustard. Toxicol Lett (2007) 1.08
Upregulation of calpain correlates with increased neurodegeneration in acute experimental auto-immune encephalomyelitis. J Neurosci Res (2005) 1.08
Spinal cord injury: a review of current therapy, future treatments, and basic science frontiers. Neurochem Res (2013) 1.08
Melatonin protects against common deletion of mitochondrial DNA-augmented mitochondrial oxidative stress and apoptosis. J Pineal Res (2007) 1.07
Estrogen receptor agonists and estrogen attenuate TNF-α-induced apoptosis in VSC4.1 motoneurons. J Endocrinol (2010) 1.07
Melatonin-induced neuroprotection after closed head injury is associated with increased brain antioxidants and attenuated late-phase activation of NF-kappaB and AP-1. FASEB J (2003) 1.07
The RNA-seq approach to discriminate gene expression profiles in response to melatonin on cucumber lateral root formation. J Pineal Res (2013) 1.07
Mechanisms of cancer inhibition by melatonin. J Pineal Res (2004) 1.06
Melatonin-mitochondria interplay in health and disease. Curr Top Med Chem (2011) 1.06
Calpeptin provides functional neuroprotection to rat retinal ganglion cells following Ca2+ influx. Brain Res (2006) 1.06
Signal transduction pathways involved in melatonin-induced neuroprotection after focal cerebral ischemia in mice. J Pineal Res (2005) 1.06
Postinjury estrogen treatment of chronic spinal cord injury improves locomotor function in rats. J Neurosci Res (2010) 1.06
Visualization of the antioxidative effects of melatonin at the mitochondrial level during oxidative stress-induced apoptosis of rat brain astrocytes. J Pineal Res (2004) 1.05
Delayed melatonin administration promotes neuronal survival, neurogenesis and motor recovery, and attenuates hyperactivity and anxiety after mild focal cerebral ischemia in mice. J Pineal Res (2008) 1.05
Melatonin, cardiolipin and mitochondrial bioenergetics in health and disease. J Pineal Res (2010) 1.04
Estrogen attenuates glutamate-induced cell death by inhibiting Ca2+ influx through L-type voltage-gated Ca2+ channels. Brain Res (2009) 1.04
Combination of all-trans retinoic acid and paclitaxel-induced differentiation and apoptosis in human glioblastoma U87MG xenografts in nude mice. Cancer (2008) 1.04
Retinoids induced astrocytic differentiation with down regulation of telomerase activity and enhanced sensitivity to taxol for apoptosis in human glioblastoma T98G and U87MG cells. J Neurooncol (2007) 1.03
Melatonin as an antioxidant: physiology versus pharmacology. J Pineal Res (2005) 1.03
Melatonin: an established antioxidant worthy of use in clinical trials. Mol Med (2008) 1.03